4 firm offers 4 generics; a couple for herron

From today's Australian:

http://www.theaustralian.com.au/business/opinion/photon-groups-100m-capital-raising-still-way-off/story-e6frg9if-1225897197224

"...Meanwhile, expect developments at Sigma Pharmaceuticals, with advisers Lazard drumming up four firm offers for Sigma's Orphan drug brands and a couple for Herron. There is also offshore interest in the generics business, most notably India's Ranbaxy. Any firm bids will be tested against the 55c-a-share takeover offer from South Africa's Aspen."

That's sounding pretty definite. Great news for SIP.